Press Releases Year None20202019201820172015 January 27, 2020 ORIC Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial of ORIC-101 in Combination with XTANDI® for the Treatment of Prostate Cancer in Collaboration with Astellas January 2, 2020 ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 12 of 12
